European Journal of Cancer and Clinical Oncology
Volume 26, Issue 5, 1990, Pages 590-593
Specialist interest articleStructure-activity relations, cytotoxicity and topoisomerase II dependent cleavage induced by pendulum ring analogues of etoposide
References (14)
- et al.
In vitro metabolism of etoposide (VP-16-213) by liver microsomes and irreversible binding of reactive intermediates to microsomal proteins
Biochem Pharmac
(1987) - et al.
Effects of the ortho-quinone and catechol of the antitumor drug VP-16-213 on the biological activity of single-stranded and double-stranded φX174 DNA
Biochem Pharmac
(1988) - et al.
Etoposide (VP-16-213): current status of an active anticancer drug
N Engl J Med
(1985) - et al.
Effects of VP-16-213 on the intracellular degradation of DNA in HeLa cells
Biochemistry
(1976) - et al.
Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP-16-213 and VM-26: a quantitative structure-activity relationship
Biochemistry
(1984) - et al.
Topoisomerase II inhibition by antitumor intercalators and demethylepipodophyllotoxins
- et al.
DNA strand breaks produced by etoposide (VP-16,213) in sensitive and resistant human breast tumor cells: implications for the mechanism of action
Cancer Res
(1988)
There are more references available in the full text version of this article.
Cited by (28)
Lifespan of etoposide-treated human neutrophils is affected by antioxidant ability of quercetin
2007, Toxicology in VitroDNA sequence selectivity of topoisomerases and topoisomerase poisons
1998, Biochimica et Biophysica Acta - Gene Structure and ExpressionAzatoxin derivatives with potent and selective action on topoisomerase II
1995, Biochemical PharmacologySynergistic interactions of etoposide and interleukin-1α are not due to DNA damage in human melanoma cells
1993, BBA - Molecular Basis of DiseaseEtoposide-induced DNA damage in human tumor cells: requirement for cellular activating factors
1991, BBA - Molecular Basis of Disease
Copyright © 1990 Published by Elsevier Ltd.